Kazia Therapeutics (KZIA) Long-Term Investments (2009 - 2021)

Kazia Therapeutics has reported Long-Term Investments for 8 years, with the latest figure at $2.1 million in Q4 2021.

• For the quarter ending Q4 2021, Long-Term Investments fell 14.48% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2021 stood at $2.1 million (down 14.48% YoY), and the FY2021 full-year result was $2.6 million, up 8.05% from the prior year.
• Long-Term Investments for Q4 2021 stood at $2.1 million, down from $2.6 million in the prior quarter.
• The five-year high for Long-Term Investments was $3.3 million in Q2 2018, with the low at $16526.6 in Q2 2017.
• Historically, Long-Term Investments has averaged $2.0 million across 5 years, with a median of $2.4 million in 2020.
• Annual changes were most pronounced in 2018 — Long-Term Investments jumped 19757.38% — and 2019, when it plunged 96.41%.
• Kazia Therapeutics' Long-Term Investments stood at $16526.6 in 2017, then surged by 11839.25% to $2.0 million in 2018, then grew by 28.49% to $2.5 million in 2019, then declined by 1.61% to $2.5 million in 2020, then retreated by 14.48% to $2.1 million in 2021.
• The last three Long-Term Investments figures came in at $2.1 million (Q4 2021), $2.6 million (Q2 2021), and $2.5 million (Q4 2020), per Business Quant data.